NIH-funded research NIH-funded research

Understanding how muscle wasting in cancer might start in a fruit-fly model

Official title: Assessing if tumor induced muscle cachexia is initiated by defects in Myosin Heavy Chain production and localization in a Drosophila tumor model

Funded at Sam Houston State University · NIH-11380906 · Data updated 2026-11-12

Researchers are studying why cancer causes muscle loss by using a fruit-fly model to see if problems with a muscle protein, myosin heavy chain, kick off cachexia.

More Cachexia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSam Houston State University
NIH-funded
Lab location1 site (Huntsville, United States)
Project startSeptember 15, 2023
Project endJuly 31, 2027
Funding year2026
Award (this year)$171,250
NIH project number5R16GM150753-04
Project IDNIH-11380906 on NIH RePORTER

Who could benefit from this research

Could help

Patients with cancer who experience or are at risk for cachexia could benefit from future diagnostics or therapies informed by these findings.

Less likely to help

Direct benefit to patients is not expected during the early basic-science work, though long-term implications may influence future treatments.

What this research studies

This project uses Drosophila to explore how cancer-related muscle wasting begins, focusing on myosin heavy chain production and where it goes in the muscle. The team will compare early vs. late changes in tissue during tumor development and test whether the Hippo signaling pathway influences these steps. They will use established staining and imaging methods and new tools that allow tissue-specific genetic changes to pinpoint causal events. Undergraduate students will actively participate, gaining hands-on training while contributing to a question that could lead to earlier diagnostics for cancer cachexia.

Why it matters

Potential benefit: If successful, findings could point to earlier diagnostic markers and new avenues to prevent or slow muscle loss in cancer patients.

How similar studies have gone: Previous models have shown that muscle wasting involves complex signaling; this study aims to clarify early events in a fruit-fly model, which is a novel approach for this specific question.

Where this research is happening

  • Sam Houston State University
    Huntsville, United States
    Active

Researchers

  • Principal investigator: Atkins, Mardelle Renee — Sam Houston State University
  • Study coordinator: Atkins, Mardelle Renee

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • CANCAN: A Virtual Institute to Cure Cancer Cachexia

    A broad, collaborative NIH initiative aims to uncover why cancer patients lose weight and muscle and to develop new ways to treat this serious condition.

    NIH research New York University School of Medicine · New York, United States · NIH-11596283

  • Adipose tissue and its role in lung cancer cachexia

    A new NIH grant explores how fat tissue around the body may feed lung cancer growth and drive weight loss, with the aim of finding ways to help patients who struggle with cancer cachexia.

    NIH research University of Vermont & St Agric College · Burlington, United States · NIH-11587408

  • Spatial metabolism mapping in cancer cachexia tissues

    Aims to map where and how metabolism changes in tissues affected by cancer cachexia using advanced imaging technology.

    NIH research Northwestern University · Chicago, United States · NIH-11539627

  • Innate inflammatory control of cachexia in chronic disease

    A research team is studying how inflammation drives cachexia in chronic disease using a parasite model to find therapies that could protect lean body mass without raising infection risk.

    NIH research University of Virginia · Charlottesville, United States · NIH-11508215

  • Nuclear receptors that may stop muscle wasting in cancer

    This grant explores whether activating specific muscle-regulating receptors can prevent muscle loss in cancer patients.

    NIH research University of Texas Hlth Sci Ctr Houston · Houston, United States · NIH-11499527

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.